Showing 181 - 200 results of 102,966 for search '(( 2 fold decrease ) OR ( 5 ((((fold decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.54s Refine Results
  1. 181
  2. 182
  3. 183
  4. 184

    WT1 siRNA decreases proliferation, pAKT, and Bcl2 expression. by Ayana E. Morales (17756335)

    Published 2024
    “…Corresponding densitometry analysis is noted as protein fold expression compared to GAPDH for WT1, p<0.001(***), vFLIP(ns), LANA p<0.05(*), pAKT p<0.05(*), and BCL2 p <0.05(*) using two-sided, unpaired student t-tests. …”
  5. 185
  6. 186
  7. 187

    Genes whose expression was decreased in RASMC subjected to Na<sup>+</sup>,K<sup>+</sup>-ATPase inhibition. by Svetlana V. Koltsova (321381)

    Published 2014
    “…Listed are assigned genes whose expression was decreased in K<sup>+</sup>-free medium by more than 3-fold and was different by less than 2-fold in the presence of ouabain compared to K<sup>+</sup>-free medium. …”
  8. 188
  9. 189
  10. 190
  11. 191
  12. 192
  13. 193
  14. 194
  15. 195

    CD34<sup>+</sup> cell populations decreased in malaria. by Carmen M. Dickinson-Copeland (824626)

    Published 2015
    “…(B) Circulating EPC numbers (CD45<sup>-</sup>CD34<sup>+</sup>VEGFR2<sup>+</sup>) are decreased in malaria patients by 1.7-fold compared with non-malaria. …”
  16. 196

    VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

    Published 2018
    “…Data for cancer subtypes are shown in boxes numbered 1–11: 1: benign breast neoplasm (rank 6459, 1.4 fold-change, NS), 2: breast carcinoma (rank 833, 1.5 fold-change, p = 3.83x10<sup>-5</sup>), 3: breast phyllodes tumor (rank 512, 1.2 fold-change, p = 0.002), 4: ductal breast carcinoma in situ (rank 1969, 1.5 fold-change, p = 0.002), 5: invasive breast carcinoma (rank 1060, 1.6 fold-change, p = 1.28x10<sup>-5</sup>), 6: invasive ductal and invasive lobular breast carcinoma (rank 941, 1.5 fold-change, p = 6.76x10<sup>-22</sup>), 7: invasive ductal breast carcinoma (rank 613, 1.5-fold change, p = 2.71x10<sup>-71</sup>), 8: invasive lobular breast carcinoma (rank 947, 1.3 fold-change, p = 3.64x10<sup>-28</sup>), 9: medullary breast carcinoma (rank 400, 1.8 fold-change, p = 3.25x10<sup>-12</sup>), 10: mucinous breast carcinoma (rank 1932, 1.4 fold-change, p = 7.41x10<sup>-10</sup>) and 11: tubular breast carcinoma (rank 1253, 1.4 fold-change, p = 1.24x10<sup>-17</sup>). …”
  17. 197
  18. 198
  19. 199
  20. 200

    Decreased splicing efficiency in DENV infected cells. by Federico A. De Maio (3091644)

    Published 2016
    “…On the lower panel, increase or decrease retention of introns for each time point is shown.…”